India, Aug. 31 -- Lifeward Ltd. (LFWD), a biomedical innovation company, on Monday announced the appointment of Josh Hexter as Interim Chief Executive Officer (CEO), effective September 1, 2026, and Rami Aviram as Chief Financial Officer (CFO), effective November 1, 2026.
Hexter succeeds Mark Grant, who will depart Lifeward to pursue other opportunities after leading the development and implementation of the company's current commercial strategy. Grant will remain as a consultant through September 30, 2026, to support the leadership transition.
Hexter brings nearly three decades of life sciences experience, including roles as Chief Operating and Business Officer at Oramed Pharmaceuticals, Chief Business Officer at BrainsWay and Executive ...